Veradigm Inc. (MDRX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 11:58AM EDT. Market open.
| Previous Close | 8.03 |
| Open | 7.60 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 1000 |
| Day's Range | 7.60 - 8.26 |
| 52 Week Range | 5.01 - 14.09 |
| Volume | |
| Avg. Volume | 4,449,877 |
| Market Cap | 839.592M |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 9.07 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Oct 07, 2008 |
| 1y Target Est | N/A |
- GuruFocus.com
Veradigm Inc (MDRX) Announces Strategic Acquisition of ScienceIO to Enhance AI Capabilities
Veradigm to Bolster Healthcare AI Platform with $140 Million ScienceIO Purchase
- Reuters
Exclusive-Netsmart's owners explore a sale valuing it at $5 billion -sources
The private equity owners of Netsmart Technologies are exploring a sale of the U.S. healthcare software firm that they hope will value it at more than $5 billion, including debt, according to people familiar with the matter. The Overland Park, Kansas-based company, which is owned by GI Partners and TA Associates, is working with investment banks Goldman Sachs Group and William Blair to launch a sale process in the coming weeks, the sources said. Netsmart expects to generate earnings before interest, taxes, depreciation and amortization of about $250 million this year, the sources added.
- GuruFocus.com
Veradigm Inc (MDRX) Issues Refreshed Fiscal 2023 Financial Estimates
New Leadership Team Outlines Strategic Vision and Updated Financial Outlook
© 2024 Yahoo. All rights reserved.